π¦
|
Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?
R. van Westrhenen,
K. Aitchison,
M. Ingelman-Sundberg,
M. Jukic
|
6 |
2020 |
6 π¦
|
π
|
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.
15 auth.
L. Beunk,
M. Nijenhuis,
Bianca Soree,
Nienke J. de Boer-Veger,
Anne M Buunk,
H. Guchelaar,
E. Houwink,
A. Risselada,
G. Rongen,
R. V. van Schaik,
...
J. Swen,
D. Touw,
R. van Westrhenen,
V. Deneer,
J. van der Weide
|
6 |
2023 |
6 π
|
π
|
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs
15 auth.
J. Brouwer,
M. Nijenhuis,
Bianca Soree,
H. Guchelaar,
J. Swen,
R. V. van Schaik,
J. Weide,
G. Rongen,
Anne M Buunk,
Nienke J. de Boer-Veger,
...
E. Houwink,
R. van Westrhenen,
B. Wilffert,
V. Deneer,
H. Mulder
|
6 |
2021 |
6 π
|
π
|
Multi-omics data integration methods and their applications in psychiatric disorders
28 auth.
A. Sathyanarayanan,
Tamara T. Mueller,
Mohammad Ali Moni,
Katja Schueler,
B. Baune,
P. LiΓ²,
D. Mehta,
B. Baune,
M. Dierssen,
Bjarke Ebert,
C. Fabbri,
P. Fusar-Poli,
M. Gennarelli,
C. Harmer,
O. Howes,
...
J. Janzing,
E. Maron,
D. Mehta,
A. Minelli,
L. Nonell,
C. Pisanu,
M. Potier,
F. Rybakowski,
A. Serretti,
Alessio Sqassina,
D. Stacey,
R. van Westrhenen,
L. Xicota
|
5 |
2023 |
5 π
|
π
|
Dutch pharmacogenetics working group (DPWG) guideline for the geneβdrug interaction between UGT1A1 and irinotecan
16 auth.
E. Hulshof,
M. Deenen,
M. Nijenhuis,
Bianca Soree,
Nienke J. de Boer-Veger,
Anne M Buunk,
E. Houwink,
A. Risselada,
G. Rongen,
R. V. van Schaik,
...
D. Touw,
J. van der Weide,
R. van Westrhenen,
V. Deneer,
H. Guchelaar,
J. Swen
|
4 |
2022 |
4 π
|
π¦
|
Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric Practice
9 auth.
R. van Westrhenen,
R. V. van Schaik,
T. van Gelder,
T. Birkenhager,
P. R. Bakker,
E. Houwink,
...
P. Bet,
W. Hoogendijk,
M. J. M. van Weelden-Hulshof
|
4 |
2021 |
4 π¦
|
π¦
|
Editorial: From Trial and Error to Individualised Pharmacogenomics-Based Pharmacotherapy in Psychiatry
R. van Westrhenen,
M. Ingelman-Sundberg
|
4 |
2021 |
4 π¦
|
π
|
Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction of CYP2D6 and COMT with atomoxetine and methylphenidate
15 auth.
M. Nijenhuis,
Bianca Soree,
W. Jama,
Nienke J. de Boer-Veger,
Anne M Buunk,
H. Guchelaar,
E. Houwink,
G. Rongen,
R. V. van Schaik,
J. Swen,
...
D. Touw,
J. van der Weide,
R. van Westrhenen,
V. Deneer,
A. Risselada
|
3 |
2022 |
3 π
|